Myovant Sciences and Pfizer Receive U.S. FDA Approval of MYFEMBREE®, a Once-Daily Treatment for the Management of Moderate to Severe Pain Associated With Endometriosis
Data from the Phase 3 SPIRIT program showed MYFEMBREE reduced menstrual pain and non-menstrual pelvic…
Spiking Joins IBM Z Day 2026 Asia Pacific Special Edition Track as a Friend of the IBM Z Community
Columbus Therapist Yvonne Judge Seeks Participants for Doctoral Research on EMDR Therapy and Family Relationships
Saudi Arabia Hit 85% Digital: The Rails Under the Card Are Next
Creative Pass Studio Launches Unlimited Design Monthly Pass, Giving Agencies and Growing Businesses a Senior Creative Team Without Adding Headcount
Stardust Appoints Eamonn McHugh as CEO in Strategic Leadership Transition